反応式
[Cl:1][C:2]1[CH:7]=[CH:6][C:5]([N:8]2[C:13](=[O:14])[CH2:12][CH2:11][CH2:10][C@H:9]2[C:15]([OH:17])=O)=[CH:4][CH:3]=1.[NH2:18][C:19]1[O:23][N:22]=[C:21]([C:24]([CH3:27])([CH3:26])[CH3:25])[CH:20]=1.N1C=CC=CC=1.P(Cl)(Cl)(Cl)=O>O>[C:24]([C:21]1[CH:20]=[C:19]([NH:18][C:15]([C@@H:9]2[CH2:10][CH2:11][CH2:12][C:13](=[O:14])[N:8]2[C:5]2[CH:4]=[CH:3][C:2]([Cl:1])=[CH:7][CH:6]=2)=[O:17])[O:23][N:22]=1)([CH3:27])([CH3:26])[CH3:25]参加物
6
反応物 4
生成物 1
試薬・触媒・溶媒 1
反応条件
- 温度
- 0 °C
実験手順
To a cold slurry of (S)-1-(4-Chloro-phenyl)-6-oxo-piperidine-2-carboxylic acid (0.2 g; 0.788 mmol) and 5-amino-3-tert-butylisoxazole (0.110 g; 0.788 mmol) in pyridine (0.956 mL; 11.820 mmol) is added phosphorous oxychloride (0.088 mL; 0.946 mmol). The mixture is stirred at 0° C. for 30 minutes and then diluted with water and extracted with ethyl acetate several times. The organics are combined and washed with water and brine, dried (Na2SO4), filtered and concentrated in vacuo. Purification by preparative HPLC affords title compound, m/z 376 [M+H+].
後処理
- extractionextracted with ethyl acetate several times
- washwashed with water and brine
- dry with materialdried (Na2SO4)
- filtrationfiltered
- concentrationconcentrated in vacuo
- customPurification by preparative HPLC
出典と根拠
- ORDレコード
- ord-cc60fa4f3eba4880b745e202d0cd6112
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08889670B2
関連ノート
読み込み中…